Cargando…
Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor
Background and Aims: Improving global health requires making current and future drugs more effective and affordable. While healthcare systems around the world are faced with increasing costs, branded and generic drug companies are facing the challenge of creating market differentiators. Two of the p...
Autor principal: | Ilan, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832873/ https://www.ncbi.nlm.nih.gov/pubmed/33477865 http://dx.doi.org/10.3390/ijerph18020811 |
Ejemplares similares
-
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
por: Ilan, Yaron
Publicado: (2022) -
Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections
por: Kolben, Yotam, et al.
Publicado: (2023) -
Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
por: Ilan, Yaron
Publicado: (2020) -
Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects
por: Azmanov, Henny, et al.
Publicado: (2022) -
Industrial Machine Learning: Using Artificial Intelligence as a Transformational Disruptor
por: Vermeulen, Andreas
Publicado: (2019)